Elena Di Gennaro - Search Results

Year	Number of Results
2003	1
2004	1
2006	1
2007	3
2009	2
2010	1
2011	4
2012	1
2013	3
2014	4
2015	2
2016	6
2017	3
2018	1
2019	3
2020	3
2021	2
2022	3

1

Tissue transglutaminase: a new target to reverse cancer drug resistance.

Budillon A, Carbone C, Di Gennaro E. Budillon A, et al. Among authors: di gennaro e. Amino Acids. 2013 Jan;44(1):63-72. doi: 10.1007/s00726-011-1167-9. Epub 2011 Dec 1. Amino Acids. 2013. PMID: 22130737 Free PMC article. Review.

2

HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer.

Lombardi R, Sonego M, Pucci B, Addi L, Iannelli F, Capone F, Alfano L, Roca MS, Milone MR, Moccia T, Costa A, Di Gennaro E, Bruzzese F, Baldassarre G, Budillon A. Lombardi R, et al. Among authors: di gennaro e. Mol Oncol. 2021 Apr;15(4):1005-1023. doi: 10.1002/1878-0261.12883. Epub 2021 Jan 19. Mol Oncol. 2021. PMID: 33331136 Free PMC article.

3

New perspective for an old antidiabetic drug: metformin as anticancer agent.

Leone A, Di Gennaro E, Bruzzese F, Avallone A, Budillon A. Leone A, et al. Among authors: di gennaro e. Cancer Treat Res. 2014;159:355-76. doi: 10.1007/978-3-642-38007-5_21. Cancer Treat Res. 2014. PMID: 24114491 Review.

4

Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.

Avallone A, Di Gennaro E, Silvestro L, Iaffaioli VR, Budillon A. Avallone A, et al. Among authors: di gennaro e. Expert Opin Drug Saf. 2014 Jan;13(1):113-29. doi: 10.1517/14740338.2014.845167. Epub 2013 Oct 5. Expert Opin Drug Saf. 2014. PMID: 24093908 Review.

5

Effect of Bevacizumab in Combination With Standard Oxaliplatin-Based Regimens in Patients With Metastatic Colorectal Cancer: A Randomized Clinical Trial.

Avallone A, Piccirillo MC, Nasti G, Rosati G, Carlomagno C, Di Gennaro E, Romano C, Tatangelo F, Granata V, Cassata A, Silvestro L, De Stefano A, Aloj L, Vicario V, Nappi A, Leone A, Bilancia D, Arenare L, Petrillo A, Lastoria S, Gallo C, Botti G, Delrio P, Izzo F, Perrone F, Budillon A. Avallone A, et al. Among authors: di gennaro e. JAMA Netw Open. 2021 Jul 1;4(7):e2118475. doi: 10.1001/jamanetworkopen.2021.18475. JAMA Netw Open. 2021. PMID: 34309665 Free PMC article. Clinical Trial.

6

Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents.

Budillon A, Di Gennaro E, Bruzzese F, Rocco M, Manzo G, Caraglia M. Budillon A, et al. Among authors: di gennaro e. Recent Pat Anticancer Drug Discov. 2007 Jun;2(2):119-34. doi: 10.2174/157489207780832450. Recent Pat Anticancer Drug Discov. 2007. PMID: 18221057 Review.

7

Epigenetic Approaches to Overcome Fluoropyrimidines Resistance in Solid Tumors.

Grumetti L, Lombardi R, Iannelli F, Pucci B, Avallone A, Di Gennaro E, Budillon A. Grumetti L, et al. Among authors: di gennaro e. Cancers (Basel). 2022 Jan 29;14(3):695. doi: 10.3390/cancers14030695. Cancers (Basel). 2022. PMID: 35158962 Free PMC article. Review.

8

Implication for Cancer Stem Cells in Solid Cancer Chemo-Resistance: Promising Therapeutic Strategies Based on the Use of HDAC Inhibitors.

Roca MS, Di Gennaro E, Budillon A. Roca MS, et al. Among authors: di gennaro e. J Clin Med. 2019 Jun 26;8(7):912. doi: 10.3390/jcm8070912. J Clin Med. 2019. PMID: 31247937 Free PMC article. Review.

9

Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance.

Iannelli F, Zotti AI, Roca MS, Grumetti L, Lombardi R, Moccia T, Vitagliano C, Milone MR, Ciardiello C, Bruzzese F, Leone A, Cavalcanti E, De Cecio R, Iachetta G, Valiante S, Ionna F, Caponigro F, Di Gennaro E, Budillon A. Iannelli F, et al. Among authors: di gennaro e. Front Cell Dev Biol. 2020 Aug 17;8:732. doi: 10.3389/fcell.2020.00732. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33015030 Free PMC article.

10

Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake.

Piro G, Roca MS, Bruzzese F, Carbone C, Iannelli F, Leone A, Volpe MG, Budillon A, Di Gennaro E. Piro G, et al. Among authors: di gennaro e. Mol Cancer Ther. 2019 Aug;18(8):1405-1417. doi: 10.1158/1535-7163.MCT-18-1117. Epub 2019 Jun 12. Mol Cancer Ther. 2019. PMID: 31189612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results